Looking ominous for post rights trading that it will follow other CR issues in recent years and trade below issue price.
Underwriters are not really having much success supporting & holding up the sp after the company boasted about placing the institutional shortfall shares at $6.00.
Best to bail out via the rights and buy back post the CR.